Online citations, reference lists, and bibliographies.

Chemistry Of Covalent Inhibition Of The Gastric (H+, K+)-ATPase By Proton Pump Inhibitors.

J. Shin, Y. M. Cho, G. Sachs
Published 2004 · Chemistry, Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Proton pump inhibitors (PPIs), drugs that are widely used for treatment of acid related diseases, are either substituted pyridylmethylsulfinyl benzimidazole or imidazopyridine derivatives. They are all prodrugs that inhibit the acid-secreting gastric (H(+), K(+))-ATPase by acid activation to reactive thiophiles that form disulfide bonds with one or more cysteines accessible from the exoplasmic surface of the enzyme. This unique acid-catalysis mechanism had been ascribed to the nucleophilicity of the pyridine ring. However, the data obtained here show that their conversion to the reactive cationic thiophilic sulfenic acid or sulfenamide depends mainly not on pyridine protonation but on a second protonation of the imidazole component that increases the electrophilicity of the C-2 position on the imidazole. This protonation results in reaction of the C-2 with the unprotonated fraction of the pyridine ring to form the reactive derivatives. The relevant PPI pK(a)'s were determined by UV spectroscopy of the benzimidazole or imidazopyridine sulfinylmethyl moieties at different medium pH. Synthesis of a relatively acid stable analogue, N(1)-methyl lansoprazole, (6b), allowed direct determination of both pK(a) values of this intact PPI allowing calculation of the two pK(a) values for all the PPIs. These values predict their relative acid stability and thus the rate of reaction with cysteines of the active proton pump at the pH of the secreting parietal cell. The PPI accumulates in the secretory canaliculus of the parietal cell due to pyridine protonation then binds to the pump and is activated by the second protonation on the surface of the protein to allow disulfide formation.



This paper is referenced by
10.1016/J.TET.2011.07.034
Synthesis and reactivity of acyclic and macrocyclic uracils bridged with five-membered heterocycles
Vyacheslav E. Semenov (2011)
10.1016/J.ELECTACTA.2013.07.173
Square-wave voltammetric determination of pantoprazole using ex situ plated antimony-film electrode
Biljana Nigović (2013)
10.21608/aprh.2018.2839.1049
Acrylamide Moiety, a Valuable Fragment in Medicinal Chemistry: Insight into Synthetic Methodologies, Chemical Reactivity and Spectrum of Biological Activities of Acrylamide Derivatives
Hossam Elgiushy (2018)
10.1039/c9ob00526a
Regioselective and oxidant-free sulfinylation of indoles and pyrroles with sulfinamides.
Yuan-Zhao Ji (2019)
10.1038/s41598-020-69246-x
DNA unchained: two assays to discover and study inhibitors of the DNA clustering function of barrier-to-autointegration factor
Michael Burger (2020)
10.1016/J.MOLCATA.2016.02.015
Catalysis without a headache: Modification of ibuprofen for the design of artificial metalloenzyme for sulfide oxidation
Laurianne Rondot (2016)
10.1007/s41061-018-0184-5
Analysis of US FDA-Approved Drugs Containing Sulfur Atoms
Kevin A. Scott (2018)
10.1002/asia.201800682
Efficient Synthesis of Five Types of Heterocyclic Compounds via Intramolecular Elimination Using Ultrasound-Static Heating Technique.
Hongfei Jiang (2018)
10.1111/j.1747-0285.2012.01334.x
The nucleotide, inhibitor, and cation binding sites of P-type II ATPases.
Mukesh Chourasia (2012)
10.1021/jo502844e
Photosensitized oxidation of aryl benzyl sulfoxides. Evidence for nucleophilic assistance to the C-s bond cleavage of aryl benzyl sulfoxide radical cations.
Tiziana del Giacco (2015)
10.1039/C7RA06883B
Ti(Phen)(OC2H5)2Cl2: a highly efficient pre-catalyst for selective oxidation of organic sulfides to sulfoxides by hydrogen peroxide
Rong-Hui Wu (2017)
10.1016/j.bcp.2013.10.026
Angiotensin (1-7) protects against stress-induced gastric lesions in rats.
Dong-lin Zhu (2014)
10.1016/j.bmc.2017.04.034
Exploration of pyrrole derivatives to find an effective potassium-competitive acid blocker with moderately long-lasting suppression of gastric acid secretion.
Haruyuki Nishida (2017)
10.1016/j.bmc.2013.01.070
Design, synthesis and pharmacological evaluation of omeprazole-like agents with anti-inflammatory activity.
Ahmed O. H. El-Nezhawy (2013)
10.1016/j.chroma.2014.08.051
Method transfer from high-pressure liquid chromatography to ultra-high-pressure liquid chromatography. I. A thermodynamic perspective.
Dennis Åsberg (2014)
10.1039/c8dt01297k
Amine-functionalized Zn(ii) MOF as an efficient multifunctional catalyst for CO2 utilization and sulfoxidation reaction.
Parth Patel (2018)
10.1124/jpet.111.185314
Characterization of a Novel Potassium-Competitive Acid Blocker of the Gastric H,K-ATPase, 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Monofumarate (TAK-438)
Jai Moo Shin (2011)
10.1016/J.SAJB.2018.09.036
Anti-ulcerogenic and proton pump (H+, K+ ATPase) inhibitory activity of Clematis flammula L. extract
Farah Yous (2018)
10.1371/journal.pone.0082286
Molecular Mechanism of Inhibition of the Mitochondrial Carnitine/Acylcarnitine Transporter by Omeprazole Revealed by Proteoliposome Assay, Mutagenesis and Bioinformatics
A. Tonazzi (2013)
10.1002/9780470909775.CH7
7. Prevacid® (Lansoprazole)
Peter Harrington (2010)
10.1016/J.MOLCATA.2010.10.002
Catalytic oxidation of organosulfides to sulfoxides using two novel Cu(II) and Ni(II) complexes with aqueous H2O2: Effect of TMAO promoter on oxidation of organosulfides
Ali Nemati Kharat (2010)
10.1080/15533174.2013.862819
Synthesis, Crystal Structure, and DNA-Binding Studies of a Cadmium(II) Complex With Bis(N-benzylbenzimidazol-2-ylmethyl)aniline
Huilu Wu (2015)
10.1039/C8DT00429C
An isotetramolybdate-supported rhenium carbonyl derivative: synthesis, characterization, and use as a catalyst for sulfoxidation.
Jingkun Lu (2018)
10.3390/pharmaceutics5030472
Proteoliposomes as Tool for Assaying Membrane Transporter Functions and Interactions with Xenobiotics
Mariafrancesca Scalise (2013)
Hip Fracture Long-term Proton Pump Inhibitor Therapy and Risk of Correction
Y. Yang (2006)
10.1021/cr200060g
The methylation effect in medicinal chemistry.
Eliezer J Barreiro (2011)
10.1002/9783527655748.CH12
Structural Alert and Reactive Metabolite Analysis for the Top 200 Drugs in the US Market by Prescription
Amit S Kalgutkar (2012)
10.1016/J.BBABIO.2008.12.019
P-type ATPases as drug targets: tools for medicine and science.
Laure Yatime (2009)
10.1080/00498254.2016.1182667
Disposition and metabolism of TAK-438 (vonoprazan fumarate), a novel potassium-competitive acid blocker, in rats and dogs
Akifumi Kogame (2017)
10.1016/J.TET.2018.07.008
Comprehensive study towards the desulfonylation/desulfinylation of cis-3-functionalized 3-phenylsulfonyl/sulfinyl-β-lactams to access novel cis-3-monosubstituted-β-lactams
Anu Kumari (2018)
Atividade osteoclástica na superfície de hidroxiapatite nano e microestruturada modulada pela presença de inibidores da bomba de protões
Hélder Tiago Gomes Silva (2014)
10.1111/j.1572-0241.2005.41956.x
Effect on Intragastric pH of a PPI with a Prolonged Plasma Half-Life: Comparison between Tenatoprazole and Esomeprazole on the Duration of Acid Suppression in Healthy Male Volunteers
R. Hunt (2005)
See more
Semantic Scholar Logo Some data provided by SemanticScholar